← Back to headlines
Lulu's and Journey Medical Forecast Positive 2026 EBITDA
Lulu's and Journey Medical have both announced projections for positive adjusted EBITDA in 2026. Lulu's plans a $2.0M-$2.5M capital expenditure, while Journey Medical intends to add up to five sales professionals.
13 May, 23:51 — 13 May, 23:51
Sources
Showing 1 of 1 sources
